Core Laboratories NV (CLB)
Working capital turnover
| Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | ||
|---|---|---|---|---|---|
| Revenue (ttm) | US$ in thousands | 520,526 | 517,009 | 504,808 | 498,822 |
| Total current assets | US$ in thousands | 226,606 | 235,227 | 233,528 | 229,047 |
| Total current liabilities | US$ in thousands | 97,586 | 94,938 | 97,598 | 85,468 |
| Working capital turnover | 4.03 | 3.69 | 3.71 | 3.47 |
December 31, 2024 calculation
Working capital turnover = Revenue (ttm) ÷ (Total current assets – Total current liabilities)
= $520,526K ÷ ($226,606K – $97,586K)
= 4.03
The working capital turnover for Core Laboratories NV has shown a positive trend over the course of the year 2024, starting at 3.47 in March and consistently increasing to 4.03 by the end of December. This indicates that the company is effectively utilizing its working capital to generate revenue. A higher working capital turnover ratio suggests that the company is managing its working capital efficiently, which can lead to improved liquidity and profitability. Overall, Core Laboratories NV's increasing working capital turnover ratio signifies a strong operational performance in terms of managing its working capital to support its business activities.
Peer comparison
Dec 31, 2024